Skip to content

WGS-guided Tracking and Infection Control Measures of CRKP

WGS-guided Tracking and Infection Control Measures of Carbapenem-resistant Klebsiella Pneumoniae

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04413305
Enrollment
1000
Registered
2020-06-02
Start date
2020-05-28
Completion date
2021-09-30
Last updated
2020-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Klebsiella Pneumoniae Infection

Brief summary

The objective of this study is to investigate the effect of the infection control measures based on the active screening of carbapenem-resistant Klebsiella pneumoniae and whole-genome based tracking and surveillance though the hospital.

Interventions

OTHERscreen of CRKP and infection control measure

For intervention group, we screen admitted patients for carbapenem-resistant Klebsiella pneumoniae and carry out 'Bundle' infection and control measures. When outbreak or tranmission of CRKP was observed, we take whole-genome sequencing to track origin and transmission route to decease CRKP rate.

Sponsors

Sumitomo Pharmaceuticals (Suzhou) Co. Ltd
CollaboratorUNKNOWN
Huashan Hospital
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. The patient was admitted to the ICU of neurosurgery in the west hospital of huashan hospital affiliated to fudan university from September 2019 to September 2021, or transferred from the ICU of another hospital 2. The patient is more than 18 years old and less than 80 years old, regardless of gender. 3. Informed consent of the patient;

Exclusion criteria

1. Patients participating in other clinical trials at the same time 2. Pregnant 4\. People who will affect the outcome of the study: whose specimens could not be received or not enough for testing

Design outcomes

Primary

MeasureTime frame
Evaluate the influence of WGS-based screen and control measures on the CRKP occurrence rate2 years

Secondary

MeasureTime frame
Analysis of transmission pattern and route pre and post WGS-based tracking2 years

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026